Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis

Objectives. Adalimumab, etanercept and infliximab are effective TNF inhibitors (TNFis) in the treatment of RA, but no randomized clinical trials have compared the three agents. Prior observational data are not consistent. We compared their effectiveness over 1 year in a prospective cohort. Methods....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Canhão, Helena, Rodrigues, Ana Maria, Mourão, Ana Filipa, Martins, Fernando, Santos, Maria José, Canas-Silva, José, Polido-Pereira, Joaquim, Pereira Silva, José Alberto, Costa, José António, Araújo, Domingos, Silva, Cândida, Santos, Helena, Duarte, Cátia, da Silva, José Antonio Pereira, Pimentel-Santos, Fernando M., Branco, Jaime Cunha, Karlson, Elizabeth W., Fonseca, João Eurico, Solomon, Daniel H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2012
Soggetti:
Clinical Science
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3475979/
https://ncbi.nlm.nih.gov/pubmed/22843791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kes184
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi